Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]

autor
Kovacovicova, Kristina
Heinmaa, Mihkel
Mistrik, Martin
vastutusandmed
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
ajakirja aastakäik number kuu
vol. 8
ilmumisaasta
leheküljed
art. 459, 7 p. : ill
võtmesõna
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
ISSN
2234-943X
TTÜ struktuuriüksus
keel
inglise
Kovacovicova, K.; Školnaja, M.; Heinmaa, M.; Mistrik, M.; Pata, P.; Pata, I. et al. Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource] // Frontiers in oncology (2018) vol. 8, art. 459, 7 p. : ill.